Modulo Bio: Funding, Investors & Team (Sep 2026)
Modulo Bio uses technology to mimic the neuroimmune system in order to identify potential medications that specifically affect microglia cells. By integrating cutting-edge advancements in stem cell biology, neuroscience, software, automation, and artificial intelligence, the company's unique neuroimmune platform is able to generate innovative therapeutic options.
Modulo Bio has raised $6.3M across 2 funding rounds on record, the most recent an undisclosed round of $500k announced in Feb 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Modulo Bio Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Modulo Bio Funding Rounds
Modulo Bio raised $5.8M in an undisclosed round announced in Nov 2024.
3 months later, an undisclosed round of $500k was announced in Feb 2025.
Modulo Bio Founders and Leadership Team
No contact details are on record for this team yet.
Modulo Bio Funding Compared to Other Biotechnology Startups
Modulo Bio's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Modulo Bio in Biotechnology and San Diego
Companies Similar to Modulo Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Modulo Bio Funding FAQs
What does Modulo Bio do?
Modulo Bio uses technology to mimic the neuroimmune system in order to identify potential medications that specifically affect microglia cells. By integrating cutting-edge advancements in stem cell biology, neuroscience, software, automation, and artificial intelligence, the company's unique neuroimmune platform is able to generate innovative therapeutic options.
How much funding has Modulo Bio raised?
Modulo Bio has raised $6.3M across 2 rounds on record. The most recent is an undisclosed round of $500k announced in Feb 2025.
When did Modulo Bio last raise funding?
Modulo Bio's most recent funding round on record is an undisclosed round of $500k, announced in Feb 2025.
Who founded Modulo Bio?
FundedIQ lists Scott Patterson (Founder) at Modulo Bio.
Where is Modulo Bio headquartered?
Modulo Bio is based in San Diego, California, United States.
How many employees does Modulo Bio have?
Modulo Bio is in the 1-10 employee band.
How does Modulo Bio's funding compare to other Biotechnology startups?
Modulo Bio's latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Modulo Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Modulo Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.